These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24340436)

  • 21. Suboptimal use of statin therapy in elderly patients with atherosclerosis: a population-based study.
    Al-Omran M; Mamdani MM; Lindsay TF; Melo M; Juurlink DN; Verma S;
    J Vasc Surg; 2008 Sep; 48(3):607-12. PubMed ID: 18585886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of treatment strategy on endothelial function.
    Tomasoni L; Sitia S; Borghi C; Cicero AF; Ceconi C; Cecaro F; Morganti A; De Gennaro Colonna V; Guazzi M; Morricone L; Malavazos AE; Marino P; Cavallino C; Shoenfeld Y; Turiel M
    Autoimmun Rev; 2010 Oct; 9(12):840-4. PubMed ID: 20678593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease.
    Meier P; Meier R; Blanc E
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):987-97. PubMed ID: 18666849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: part II.
    Armani A; Becker RC
    Am Heart J; 2005 Jun; 149(6):977-83. PubMed ID: 15976778
    [No Abstract]   [Full Text] [Related]  

  • 25. Inflammatory disorders and atherosclerosis: new therapeutic approaches.
    Charakida M; O'Neil F; Masi S; Papageorgiou N; Tousoulis D
    Curr Pharm Des; 2011 Dec; 17(37):4111-20. PubMed ID: 22204372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.
    McLaren JE; Michael DR; Ashlin TG; Ramji DP
    Prog Lipid Res; 2011 Oct; 50(4):331-47. PubMed ID: 21601592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How can we prevent cardiovascular disease in diabetes.
    Wiklund O; Håversen L; Pettersson C; Hultén LM
    J Intern Med; 2007 Aug; 262(2):199-207. PubMed ID: 17645587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Statins in COPD--theoretical reflections].
    Hannink JD; Heijdra YF
    Ned Tijdschr Geneeskd; 2010; 154():A2196. PubMed ID: 20977805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toward immunomodulatory and anti-inflammatory properties of statins.
    Arnaud C; Braunersreuther V; Mach F
    Trends Cardiovasc Med; 2005 Aug; 15(6):202-6. PubMed ID: 16182129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High HDL may not protect the heart. Concentrate on lowering LDL for now, experts advise.
    Harv Heart Lett; 2012 Sep; 23(1):6. PubMed ID: 23097807
    [No Abstract]   [Full Text] [Related]  

  • 31. Psoriasis: can statins play a dual role?
    Rajpara AN; Goldner R; Gaspari A
    Dermatol Online J; 2010 Feb; 16(2):2. PubMed ID: 20178698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-inflammatory action of statins and reduction of homocysteinemia by vitamin supplementation: interactions among strategies for cardiovascular prevention.
    Rubba P
    Nutr Metab Cardiovasc Dis; 2000 Aug; 10(4):173-6. PubMed ID: 11079254
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.
    Patrick L; Uzick M
    Altern Med Rev; 2001 Jun; 6(3):248-71. PubMed ID: 11410071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rosuvastatin and progression of atherosclerosis.
    Nicholls SJ
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):925-33. PubMed ID: 18666843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Should the treatment of diabetic dyslipidemia be modified after the Action to Control Cardiovascular Risk in Diabetes Lipid study?].
    Pérez A
    Endocrinol Nutr; 2010 Dec; 57(10):457-9. PubMed ID: 20688585
    [No Abstract]   [Full Text] [Related]  

  • 36. Regarding "Suboptimal use of statin therapy in elderly patients with atherosclerosis: a population-based study".
    Goldstein MR; Mascitelli L; Pezzetta F
    J Vasc Surg; 2009 Jun; 49(6):1632-3; author reply 1633. PubMed ID: 19497532
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunomodulation by statins: mechanisms and potential impact on autoimmune diseases.
    Chow SC
    Arch Immunol Ther Exp (Warsz); 2009; 57(4):243-51. PubMed ID: 19578811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innate immune molecular connections between atherosclerosis and statins: can the clinical laboratory venture beyond C-reactive protein?
    Staros EB
    Am J Clin Pathol; 2006 Jan; 125(1):8-15. PubMed ID: 16482986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial dysfunction: potential clinical implications.
    Tousoulis D; Koutsogiannis M; Papageorgiou N; Siasos G; Antoniades C; Tsiamis E; Stefanadis C
    Minerva Med; 2010 Aug; 101(4):271-84. PubMed ID: 21030938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The challenge of traditional Chinese medicines for allopathic practitioners.
    Karalliedde LD; Kappagoda CT
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H1967-9. PubMed ID: 19855052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.